Prostate News Archive
19-Jul-2011
Hormone therapy extends life of some prostate cancer patients
Men diagnosed with prostate cancer are routinely given a harsh hormone therapy treatment for four months - it suppresses the production of the male sex hormone testosterone - but little was known about how effective that treatment was at increasing the odds of survival in those with early- and intermediate-stage disease. So researchers decided to test whether giving the drugs ... PSA Test Reduces Risk of Spread if Prostate Cancer Strikes
MONDAY, Oct. 25 (HealthDay News) -- Having a prostate-specific antigen (PSA) test to screen for prostate cancer reduces the risk that if cancer develops it will spread to other parts of the body, new research indicates. Could Hair Loss at 20 Signal Higher Prostate Cancer Risk?
TUESDAY, Feb. 15 (HealthDay News) -- Men with prostate cancer may be twice as likely to have started showing signs of male pattern baldness at the age of 20 than those without prostate cancer, a new French study suggests. Prostate Cancer Screening No Benefit to Older Men With Low PSA Levels
MONDAY, Sept. 13 (HealthDay News) -- Although many men are concerned about prostate cancer, a new study finds that in men aged 55 to 74 with low levels of baseline prostate-specific antigen (PSA), further screening and early detection of prostate cancer offer virtually no benefit.
Back to Prostate News Archive
